ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+102.07%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$346M
AUM Growth
+$346M
(+68%)
Cap. Flow
+$58.9M
Cap. Flow
% of AUM
17.01%
Top 10 Holdings %
Top 10 Hldgs %
48.64%
Holding
51
New
19
Increased
11
Reduced
14
Closed
5
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$19.3M |
| 2 |
Celldex Therapeutics
CLDX
|
$13M |
| 3 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$11.7M |
| 4 |
Kura Oncology
KURA
|
$11M |
| 5 |
Immunovant
IMVT
|
$8.52M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$18M |
| 2 |
Aurinia Pharmaceuticals
AUPH
|
$11.2M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$7.45M |
| 4 |
Larimar Therapeutics
LRMR
|
$7.02M |
| 5 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$5.53M |
Sector Composition
| 1 | Healthcare | 91.39% |